Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01076920 | Mesenchymal Stem Cells and Myocardial Ischemia | PHASE1 | COMPLETED | 10 | — | — | Oct 1, 2009 | Sep 1, 2014 | Sep 19, 2014 | 1 | France |
| Arm | Type | Description |
|---|---|---|
| Intervention arm | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Mesenchymal stem cells | GENETIC | 60x106 MSCs Trans-endocardial intramyocardial injections (n=14-16) |
Inclusion Criteria: 1. Age 18 to 75 2. Male or female 3. NYHA (Heart failure) Class II-IV or Angina pectoris CCS Class III or IV or symptoms consistent with) 4. Chronic coronary artery disease with left ventricular function below 35% 5. Stable medical therapy for at least one month 6. Reversible pe...